Celularity Inc

For the period ended Oct 29, 2026. Filed Oct 29, 2026.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Oct 29, 2026 · Filed Oct 29, 2026

Use the contents to explore the available documents and sections.

CELU$0.76+4.8%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.1 · About Celularity

About Celularity

Celularity Inc. (Nasdaq: CELU) is a longevity-focused regenerative and cellular medicine company developing and manufacturing allogeneic and autologous cell therapies and biomaterials. Celularity’s regenerative longevity vision centers on advancing technologies intended to address aging and age-related conditions and extend healthspan. Its purpose-built facility in Florham Park, New Jersey supports manufacturing, research and biobanking activities. Celularity also pursues contract development and manufacturing opportunities that apply its infrastructure and technical expertise to third-party programs.

For more information, visitwww.celularity.com.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.